Work

Safety and interim results from a phase II, single-arm study of atezolizumab and bevacizumab in Merkel cell carcinoma (MCC).

Year: 2019

Type: conference-abstract

Source: Journal of Clinical Oncology

DOI: 10.1200/jco.2019.37.15_suppl.e21006

Authors: Renata Ferrarotto, Javier Mata, Frank Mott, Priya Bhosale, M. Laura Rubin, Mehmet Altan, Shannon Dervin, Cindy Yun, James C. Yao, Daniel M. Halperin

Institutions: The University of Texas MD Anderson Cancer Center, Genentech

Language: English

Topic: Polyomavirus and related diseases

Subfield: Oncology

Field: Medicine

Domain: Health Sciences

SDG: Good health and well-being

Open Access status: closed

OpenAlex ID: W2947047531

Cites:

Cited by: 5

Related to: 10